Is Compounded Semaglutide Legit and Safe?

"Is compounded semaglutide legit?" is really two questions wearing one coat: is it legal, and is it safe? The answers are different, and conflating them is how people talk themselves into bad decisions. Legal is a floor. Safe is a judgment you make about a specific pharmacy and a specific provider. Here is how to tell them apart.

Legal: yes, within a defined framework Pharmacy compounding is a long-standing, lawful practice. Federal law authorizes it under two sections. Section 503A covers a licensed pharmacist compounding a drug for an individual patient in a state-licensed pharmacy; section 503B covers registered "outsourcing facilities" that compound in larger batches under current good manufacturing practice (CGMP) requirements[[cite:1]]. So compounded semaglutide can be entirely legal. But "legal" comes with a critical asterisk explained next — it is not the same as "FDA-approved."

Not the same as FDA-approved Compounded drugs are not FDA-approved and do not go through the agency's premarket review for safety, effectiveness, or manufacturing quality[[cite:2]]. The approved semaglutide product, Wegovy, carries FDA-reviewed labeling that specifies its doses, warnings, and contraindications[[cite:3]]; a compounded version does not have an equivalent individual review behind it. This is the single most important thing to internalize: legal and reviewed are two different bars, and compounded clears the first without clearing the second.

Safe: it depends on who made it Because compounded semaglutide is not individually reviewed, its safety leans heavily on the quality of the pharmacy that prepared it. This is where the 503A/503B distinction becomes practical rather than academic. A 503B outsourcing facility operates under FDA CGMP requirements — a manufacturing standard closer to a brand maker's. A 503A pharmacy operates under state licensure and is not held to CGMP. Neither is disqualifying, but they are not equivalent, and a provider that will not tell you which type of pharmacy fills your prescription has failed the first safety test.

What "legit" looks like in practice Beyond the pharmacy type, a legitimate operation shows its work:

A licensed prescriber reviews your medical history before prescribing, rather than a form that approves everyone. The pharmacy is identifiable, licensed, and — for the ones that pursue it — carries LegitScript certification, an independent verification that a telehealth or pharmacy operation meets defined legal and safety standards. The provider discloses the formulation, concentration, and sourcing, and gives you a real path to a clinician if a side effect appears. And the same GLP-1 warnings apply: the class carries a boxed warning about thyroid C-cell tumors seen in rodents and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2³. A legitimate provider surfaces those risks; it does not bury them.

Red flags that override a low price No prescriber contact and no medical intake worth the name. Refusal to name the pharmacy or its 503A/503B status. Claims that a compounded product is "FDA-approved" — it is not, and saying so is a lie you can catch. No monitoring, no labs, no way to reach a human when something goes wrong. Any one of these should outweigh an attractive monthly price.

The honest bottom line Compounded semaglutide can be both legal and reasonably safe — when it comes from a transparent, well-run pharmacy through a provider with real clinical oversight. It can also be neither. The category does not decide that; the specific provider does. Vet the provider with our [six-point checklist](/how-to-choose-a-glp1-provider), understand the trade-offs in [compounded vs. brand-name GLP-1](/compounded-vs-brand-name-glp1), and see how graded providers compare in our [reviews](/research). None of this is medical advice — a licensed clinician who knows your history should make the final call.